The emerging approach of this peptide represents a major development in the management of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets dual pathways – GLP-1 and GIP – providing https://tirzepatidepeptide960994.jts-blog.com/40580394/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment